TWD
INMB icon

True Wealth Design’s INmune Bio INMB Stock Holding History

True Wealth Design’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475 Buy
291
+280
+2,545% +$387 ﹤0.01% 2218
2026
Q1 		$13 Buy
+11
New +$16 ﹤0.01% 2660

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

True Wealth Design's INMB Position: Q2 2026 in Review

True Wealth Design increased its INmune Bio (INMB) stake by 2,545% in Q2 2026, buying an estimated $387 and bringing the position to 291 shares worth $475. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

True Wealth Design first reported a position in INMB in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • True Wealth Design held 291 shares of INmune Bio worth $475 as of Q2 2026.
  • True Wealth Design bought 280 INmune Bio shares in Q2 2026, an estimated $387.
  • INmune Bio made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2218 holding.
  • True Wealth Design first reported a position in INmune Bio in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.